| RS886041562 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041563 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Lymphangiomyomatosis |
| RS886041564 |
WAC
|
Health Risk |
Likely pathogenic |
— |
| RS886041565 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Fibromatosis |
| RS886041566 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS886041567 |
CEP164
|
Health Risk |
Pathogenic |
— |
| RS886041568 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS886041569 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041570 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS886041571 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS886041572 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS886041573 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041574 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886041575 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041576 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS886041577 |
FUS
|
Health Risk |
Pathogenic |
— |
| RS886041578 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS886041579 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS886041580 |
CDC73
|
Health Risk |
Pathogenic |
— |
| RS886041581 |
MED12
|
Health Risk |
Pathogenic |
— |
| RS886041582 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886041583 |
ZIC2
|
Health Risk |
Pathogenic |
— |
| RS886041584 |
SELENON
|
Health Risk |
Pathogenic |
Congenital myopathy 4A, autosomal dominant |
| RS886041586 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS886041587 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS886041588 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041589 |
DDX3X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS886041590 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS886041591 |
PIK3R2
|
Health Risk |
Pathogenic |
Seizure, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 |
| RS886041592 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, 6 conditions |
| RS886041593 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, See cases |
| RS886041594 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS886041595 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS886041596 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS886041597 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS886041598 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS886041600 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS886041601 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS886041602 |
PIK3R2
|
Health Risk |
Pathogenic |
— |
| RS886041603 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS886041604 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041605 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS886041606 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS886041607 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS886041608 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS886041609 |
AUTS2
|
Health Risk |
Pathogenic |
— |
| RS886041610 |
PTCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS886041611 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886041612 |
ERLIN2
|
Health Risk |
Pathogenic |
— |
| RS886041613 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS886041614 |
WAC
|
Health Risk |
Pathogenic |
Rare genetic intellectual disability, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS886041615 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886041616 |
XYLT1
|
Health Risk |
Pathogenic |
— |
| RS886041617 |
KCNB1
|
Health Risk |
Pathogenic |
— |
| RS886041618 |
WNT10A
|
Health Risk |
Pathogenic |
— |
| RS886041619 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS886041620 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS886041621 |
GATAD2B
|
Health Risk |
Pathogenic |
GATAD2B-related disorder, GATAD2B-related intellectual disability syndrome |
| RS886041623 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886041624 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS886041625 |
FBXL4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS886041626 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041627 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886041628 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS886041629 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886041630 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS886041631 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041632 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886041633 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS886041634 |
MEN1
|
Health Risk |
Pathogenic |
— |
| RS886041635 |
CAMTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS886041636 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS886041637 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS886041638 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS886041639 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS886041640 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS886041641 |
DNMT3A
|
Health Risk |
Pathogenic |
— |
| RS886041643 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041644 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041645 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS886041646 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS886041647 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, NFIX-related disorder |
| RS886041648 |
PLP1
|
Health Risk |
Pathogenic |
— |
| RS886041649 |
GPT2
|
Health Risk |
Pathogenic |
— |
| RS886041650 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS886041651 |
POMK
|
Health Risk |
Pathogenic |
— |
| RS886041652 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS886041653 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886041654 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS886041655 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS886041656 |
PEX5
|
Health Risk |
Pathogenic |
— |
| RS886041657 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS886041658 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS886041659 |
FMN2
|
Health Risk |
Pathogenic |
— |
| RS886041660 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886041661 |
POLR1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 11, Treacher Collins syndrome 3 |
| RS886041662 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS886041664 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS886041665 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886041666 |
STX1B
|
Health Risk |
Pathogenic |
— |